Boardroom Alpha
10-K primary document
FTRE · Annual Report (Form 10-K) · Filed February 26, 2026

Fortrea Holdings Inc10-K exhibit

exhibit21-listofsubsidiari.htm
Document

Exhibit 21

List of Subsidiaries of the Company

Entity Name
Jurisdiction of Formation
Fortrea Argentina S.A.Argentina
Fortrea Australia Pty LtdAustralia
Fortrea Austria GmbHAustria
Fortrea Belgium SRLBelgium
Fortrea Brazil LimitadaBrazil
Fortrea Development Limited - Bulgarian BranchBulgaria
Theorem Research Associates, Inc.California
Fortrea Canada Inc.Canada
Fortrea Chile LimitadaChile
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Chengdu BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Nanjing BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Shanghai BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Xi’an BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd. Dalian BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd. Guangzhou BranchChina
Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd., Hangzhou BranchChina
Fortrea Pharmaceutical Research and Development (Beijing)Co., Ltd.China
Fortrea Colombia LtdaColombia
Fortrea Costa Rica SRLCosta Rica
Fortrea Development Limited odštěpný závod
Czechia
Fortrea Asia-Pacific Inc.Delaware
Fortrea CRU Inc.Delaware
Fortrea Holdings Inc.Delaware
Fortrea Latin America Inc.Delaware
Fortrea Receivables LLCDelaware
SnapIoT, Inc.Delaware
Fortrea Denmark ApSDenmark
Fortrea Development Limited Eesti filiaalEstonia
Fortrea Development Limited Suomen sivuliikeFinland
Fortrea Clinical Research Unit Inc.Florida
Fortrea France SARLFrance
Fortrea Germany GmbHGermany
Fortrea Development Limited Greek BranchGreece
Fortrea Guatemala S.A.Guatemala
Fortrea Hong Kong LimitedHong Kong




Fortrea Hungary KftHungary
Fortrea Clinical Development Pvt LtdIndia
Fortrea Development India Private LimitedIndia
Fortrea Scientific Private LimitedIndia
Fortrea Ireland LimitedIreland
Fortrea Development LimitedIsrael
Fortrea Development Limited Filiale Italiana Italy
SnapIoT Europe s.r.l.Italy
Fortrea Japan K.K.Japan
Fortrea Korea LimitedKorea, Republic Of
Fortrea Development Limited Latvijas filiāle
Latvia
Fortrea Development Limited filialasLithuania
Fortrea Malaysia Sdn. Bhd.Malaysia
Fortrea Inc.Maryland
Fortrea Clinical Development Mexico S.DeR.L.DeC.V.Mexico
Fortrea Netherlands B.V.Netherlands
Theorem Clinical Research Holdings B.V.Netherlands
Theorem Clinical Research International B.VNetherlands
Theorem Clinical Research Latin America B.V.Netherlands
Fortrea New Zealand LimitedNew Zealand
Fortrea Development LimitedNorway
Fortrea GP, Inc.Nevada
Fortrea Research Holdings LLCNevada
Fortrea Peru S.A.Peru
Fortrea Philippines Inc.Philippines
Fortrea Poland Sp. z o.o.Poland
Fortrea Development Limited Sucursal em PortugalPortugal
Fortrea Development Limited Maidenhead Sucursala BucurestiRomania
Fortrea Development Limited (Moscow)Russian Federation
Fortrea Development Limited (St Petersburg)Russian Federation
Fortrea Development Limited Predstavništvo
Serbia
Fortrea Singapore Pte. Ltd.Singapore
Fortrea Development Limited - o.z.Slovakia
Fortrea South Africa (Pty) LimitedSouth Africa
Fortrea Spain SASpain
Fortrea Development Limited Sverige filialSweden
Fortrea Switzerland AGSwitzerland
Fortrea Taiwan LimitedTaiwan, Province Of China
Fortrea (Thailand) LimitedThailand
Fortrea Turkey Clinical Study Limited CompanyTurkey
Fortrea Clinical Research LPTexas
Fortrea Data Sciences Ukraine LLCUkraine
Fortrea Development Ukraine LLCUkraine
Chiltern International Limited (CIL)United Kingdom




Fortrea Clinical Research Unit LimitedUnited Kingdom
Fortrea Development LimitedUnited Kingdom
Fortrea UK Holdings LimitedUnited Kingdom
Havenfern LtdUnited Kingdom


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer